Site-specific cleavage of RNA by Fe(II)·bleomycin

Barbara J. Carter, Erik De Vroom, Eric C. Long, Gijs A. Van Der Marel, Jacques H. Van Boom, Sidney Hecht

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Bleomycin is an antitumor agent whose activity (us long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacillus subtilis tRNAHis incursor in a highly selective fashion, but Escherichia coli tRNATyr precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, ≈ 10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single- and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity of mechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.

Original languageEnglish (US)
Pages (from-to)9373-9377
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume87
Issue number23
StatePublished - 1990
Externally publishedYes

Fingerprint

RNA
Bleomycin
RNA, Transfer, His
RNA, Transfer, Tyr
RNA Cleavage
RNA Sequence Analysis
DNA Cleavage
RNA primers
iron bleomycin
Xenobiotics
Bacillus subtilis
Antineoplastic Agents
Nucleotides
Escherichia coli
DNA

Keywords

  • Antitumor antibiotic
  • Human immunodeficiency virus reverse transcriptase mRNA
  • Mechanism of action
  • Oxidative degradation
  • TRNA precursors

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Carter, B. J., De Vroom, E., Long, E. C., Van Der Marel, G. A., Van Boom, J. H., & Hecht, S. (1990). Site-specific cleavage of RNA by Fe(II)·bleomycin. Proceedings of the National Academy of Sciences of the United States of America, 87(23), 9373-9377.

Site-specific cleavage of RNA by Fe(II)·bleomycin. / Carter, Barbara J.; De Vroom, Erik; Long, Eric C.; Van Der Marel, Gijs A.; Van Boom, Jacques H.; Hecht, Sidney.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 23, 1990, p. 9373-9377.

Research output: Contribution to journalArticle

Carter, BJ, De Vroom, E, Long, EC, Van Der Marel, GA, Van Boom, JH & Hecht, S 1990, 'Site-specific cleavage of RNA by Fe(II)·bleomycin', Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 23, pp. 9373-9377.
Carter, Barbara J. ; De Vroom, Erik ; Long, Eric C. ; Van Der Marel, Gijs A. ; Van Boom, Jacques H. ; Hecht, Sidney. / Site-specific cleavage of RNA by Fe(II)·bleomycin. In: Proceedings of the National Academy of Sciences of the United States of America. 1990 ; Vol. 87, No. 23. pp. 9373-9377.
@article{3819dcd18f0a42bf9848cf31e82677f3,
title = "Site-specific cleavage of RNA by Fe(II)·bleomycin",
abstract = "Bleomycin is an antitumor agent whose activity (us long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacillus subtilis tRNAHis incursor in a highly selective fashion, but Escherichia coli tRNATyr precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, ≈ 10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single- and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity of mechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.",
keywords = "Antitumor antibiotic, Human immunodeficiency virus reverse transcriptase mRNA, Mechanism of action, Oxidative degradation, TRNA precursors",
author = "Carter, {Barbara J.} and {De Vroom}, Erik and Long, {Eric C.} and {Van Der Marel}, {Gijs A.} and {Van Boom}, {Jacques H.} and Sidney Hecht",
year = "1990",
language = "English (US)",
volume = "87",
pages = "9373--9377",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "23",

}

TY - JOUR

T1 - Site-specific cleavage of RNA by Fe(II)·bleomycin

AU - Carter, Barbara J.

AU - De Vroom, Erik

AU - Long, Eric C.

AU - Van Der Marel, Gijs A.

AU - Van Boom, Jacques H.

AU - Hecht, Sidney

PY - 1990

Y1 - 1990

N2 - Bleomycin is an antitumor agent whose activity (us long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacillus subtilis tRNAHis incursor in a highly selective fashion, but Escherichia coli tRNATyr precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, ≈ 10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single- and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity of mechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.

AB - Bleomycin is an antitumor agent whose activity (us long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacillus subtilis tRNAHis incursor in a highly selective fashion, but Escherichia coli tRNATyr precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, ≈ 10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single- and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity of mechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.

KW - Antitumor antibiotic

KW - Human immunodeficiency virus reverse transcriptase mRNA

KW - Mechanism of action

KW - Oxidative degradation

KW - TRNA precursors

UR - http://www.scopus.com/inward/record.url?scp=0025608830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025608830&partnerID=8YFLogxK

M3 - Article

C2 - 1701259

AN - SCOPUS:0025608830

VL - 87

SP - 9373

EP - 9377

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 23

ER -